Home › Research › Topics › eye
eye
151 studies tagged eye, dated 1986-08-01 to 2026-10-22. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Retinal biomarkers and dementia risk: A review of evidence across the 14 Lancet modifiable risk factors for dementia 2026-10-22
- Multimodal Retinal Imaging for the Detection of Early Alzheimer’s Disease: Combining Biochemical, Structural, and Vascular Biomarkers 2026-08-17
- Electroretinography as a Noninvasive Biomarker of Alzheimer’s Disease and Related Dementias in Older Adults: A Systematic Scoping Review 2026-07-30
Studies
151 studies carry this tag.
Date range
1986 to 2026
Top journals
- Journal of Alzheimer's disease : JAD 13
- Alzheimer's & dementia (Amsterdam, Netherlands) 7
- Progress in retinal and eye research 7
- Alzheimer's & dementia : the journal of the Alzheimer's Association 4
- Investigative ophthalmology & visual science 4
89 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
In diabetic retinopathy, venous oxygen saturation increases and arteriovenous difference decreases.
-
45/100
AimTo evaluate visual dysfunction and its correlation with structural changes in the retina in patients with Alzheimer's disease (AD).MethodsPatients with AD (n=24) and controls (n=24) underwent evaluation of visual acuity (VA), color vision (using the Farnsworth and L'Anthony desaturated (D) 15 color tests), and contrast sensitivity vision (CSV; using the Pelli-Robson chart and CSV-1000E test) to measure visual dysfunction.
-
Retinal thickness is decreased in AD and MCI patients compared to HC.
-
Interest in reliable biomarkers of Alzheimer disease, the leading cause of dementia, has been fuelled by challenges in diagnosing the disease and monitoring disease progression as well as the response to therapy.
-
Ten studies assessing retinal properties in dementia were included.
-
Alzheimer's disease (AD) is a progressive neurodegenerative disorder resulting in dementia and eventual death.
-
The purpose of this article is to review the main findings on OCT in AD patients, to discuss the role of this important diagnostic tool in these patients and how OCT technology may be useful in understanding morphological retinal changes in AD.
-
The surface area of inclusion bodies increased as a function of cortical amyloid burden.
-
Although historically perceived as a disorder confined to the brain, our understanding of Alzheimer's disease (AD) has expanded to include extra-cerebral manifestation, with mounting evidence of abnormalities in the eye.
-
Central nervous system (CNS) pathologies have ocular manifestations due to direct and/or retrograde degeneration of the visual pathways, most often related to a direct injury to the optic nerve, retinal ganglion cells and/or its surrounding cells.
-
We show variable degrees of rest-activity circadian dysfunction in AD patients.
-
Age-related cataracts are frequently associated with degenerative changes in the ocular lens including the aggregation of proteins - mainly crystallins, but also other proteins including amyloids (Aβ) leading to the hypothesis that cataracts could be used as "biomarkers" for Alzheimer disease.
-
Although cerebral small vessel disease has been linked to stroke and dementia, due to limitations of current neuroimaging technology, direct in vivo visualization of changes in the cerebral small vessels (e.g., cerebral arteriolar narrowing, tortuous microvessels, blood-brain barrier damage, capillary microaneurysms) is difficult to achieve.
-
Alzheimer's disease (AD) is a devastating neurodegenerative disease characterised clinically by a progressive decline in executive functions, memory and cognition.
-
Our data strengthens the link between retinal ganglion cell neuronal and optic nerve axonal loss with AD, and suggest that assessment of macular GC-IPL can be a test to detect neuronal injury in early AD and MCI.
-
Although cerebral small vessel disease has been implicated in the development of Alzheimer's disease (AD), the cerebral microcirculation is difficult to visualize directly in vivo.
-
Primary open angle glaucoma (POAG) is a complex progressive optic nerve neuropathy triggered by both environmental and genetic risk factors.
-
These results indicate that RNFL and RNFL+GCL thickness measurements are reduced in AD patients compared with healthy subjects.
-
Alzheimer's disease (AD) is the most common form of dementia.
-
The aim of this study was to investigate retinal nerve fiber layer (RNFL) thickness in patients with Alzheimer disease (AD) without visual impairment using spectral domain optical coherence tomography (SD-OCT) and to compare the results with healthy controls.
-
The earliest detectable change in Alzheimer's disease (AD) is the buildup of amyloid plaque in the brain.
-
We review the cellular and physiological mechanisms responsible for the regulation of blood flow in the retina and choroid in health and disease.
-
Our data confirm the retinal involvement in AD, as reflected by loss of axons in the optic nerves.
-
Age is a common risk factor for Alzheimer's disease (AD) and age-related macular degeneration (AMD).
-
Age-related macular degeneration (AMD) is a late-onset, neurodegenerative retinal disease that shares several clinical and pathological features with Alzheimer's disease (AD), including stress stimuli such as oxidative stress and inflammation.
-
Noninvasive monitoring of β-amyloid (Aβ) plaques, the neuropathological hallmarks of Alzheimer's disease (AD), is critical for AD diagnosis and prognosis.
-
Alzheimer's disease (AD) patients often have visual disorders which may be due to retinal nerve degenerative changes.
-
Ophthalmologic abnormalities have been described in patients with dementia, but the extent to which poor vision and treatment for visual disorders affect cognitive decline is not well defined.
-
Visual impairment is a common symptom of Alzheimer's disease (AD).
-
Retinal abnormalities in early AD include a specific pattern of RNFL loss, narrow veins, and decreased retinal blood flow in these veins.
-
36/100
In Alzheimer's disease (AD), brain lesions are marked by severe neuronal loss and retinal degeneration was previously mentioned in affected patients.
-
Glaucoma is a leading cause of irreversible world vision loss characterized by progressive retinal ganglion cell death.
-
In sprouting angiogenesis, specialized endothelial tip cells lead the outgrowth of blood-vessel sprouts towards gradients of vascular endothelial growth factor (VEGF)-A. VEGF-A is also essential for the induction of endothelial tip cells, but it is not known how single tip cells are selected to lead each vessel sprout, and how tip-cell numbers are determined.
-
Our study confirms some other studies in showing that in AD patients there is a reduction of parapapillary and macular RNFL thickness and macular volume as measured by OCT.
-
Apoptotic nerve cell death is implicated in the pathogenesis of several devastating neurodegenerative conditions, including glaucoma and Alzheimer's and Parkinson's diseases.
-
The noninvasive techniques of static and dynamic light scattering are emerging as valuable diagnostic tools for the early detection of ocular and systemic diseases.
-
Abeta was present in 4 of 9 AMD eyes.
-
The results support a role for local inflammation in drusen biogenesis, and suggest that it is analogous to the process that occurs in other age-related diseases, such as Alzheimer's disease and atherosclerosis, where accumulation of extracellular plaques and deposits elicits a local chronic inflammatory response that exacerbates the effects of primary pathogenic stimuli.
-
Rat RGCs subjected to chronic ocular hypertension demonstrate caspase activation and abnormal processing of APP, which may contribute to the pathophysiology of glaucoma.
-
The purpose of the current study was to reveal the occurrence rate of glaucoma among patients with Alzheimer's disease (AD).
-
Our results suggest that in AD patients, there is a reduction of NFL thickness evaluated in vivo by OCT and this morphological abnormality is related to a retinal dysfunction as revealed by abnormal PERG responses.
-
Morphometric analysis of the numbers of neurons in the ganglion cell layer (GCL) of the central retina (fovea/foveola/parafoveal retina) in eyes from 9 Alzheimer's disease (AD) and 11 age-matched control cases revealed an overall decrease of 25% in total numbers of neurons in AD as compared with control eyes.
-
Detailed analyses of neuronal and astrocyte cell numbers in the ganglion cell layer (GCL) of whole-mounted peripheral retinas from 16 Alzheimer's disease (AD) and 11 control eyes (11 and 9 cases, respectively) demonstrate extensive neuronal loss throughout the entire retina in AD as compared to control eyes.
-
Optic nerve and retinal ganglion cell (GC) degeneration are possible explanations for the poor visual function reported in patients with Alzheimer's disease (AD).
-
Visual impairment is associated with both an increased risk and an increased clinical severity of Alzheimer's disease, but the increased risk may not be consistent with a progressive dose-response relationship.
-
In patients with Alzheimer's disease (AD), compared with age-matched and young healthy control subjects, visual deficits in the following functions were observed: color, stereoacuity, contrast sensitivity, and backward masking (homogeneous and pattern).
-
Optic nerves from ten patients with Alzheimer's disease were histologically examined and compared with those from age-matched controls.
-
This study documents the light-microscopic and ultrastructural characteristics of ganglion cell degeneration in the retinas of patients with Alzheimer's disease (AD).
-
Visually impaired individuals were more likely to develop incident dementia, with a progressively greater risk among those with worse visual acuity.
-
We examined five patients with Alzheimer's disease who complained of poor vision.
From across this tag
7 of the 151 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 7. The same 7 appear here every time.
- Ocular biomarkers of cognitive decline based on deep-learning retinal vessel segmentation
- Alzheimer's Disease Seen through the Eye: Ocular Alterations and Neurodegeneration
- Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas
- ROSE: A Retinal OCT-Angiography Vessel Segmentation Dataset and New Model
- Hyperspectral retinal imaging in Alzheimer's disease and age-related macular degeneration: a review
- The Parietal Lobe in Alzheimer's Disease and Blindness
- Retina Oculomics in Neurodegenerative Disease